s6y
Company name or ticker
Search
SAB Biotherapeutics, Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Friday, August 21, 2026
Accession number
0001193125-26-361180
Documents
424B3
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header